Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
Biologic drugs are used to treat a variety of cancers and chronic diseases. While most of
these treatments are administered intravenously by trained healthcare professionals, a …
these treatments are administered intravenously by trained healthcare professionals, a …
Inflammatory Bowel Disease Patients' Preferences for Subcutaneous versus Intravenous Therapies: A Mixed-Methods Study
WK van Deen, C Khalil, NN Bonthala, R Gale… - Digestive …, 2023 - karger.com
Background: Multiple biologics are available to treat inflammatory bowel disease (IBD),
which can either be administered subcutaneously or intravenously. The factors that …
which can either be administered subcutaneously or intravenously. The factors that …
Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective
T Purmonen, K Puolakka, D Bhattacharyya… - Cost Effectiveness and …, 2018 - Springer
Objective To study cost-effectiveness of an interleukin (IL)-17A inhibitor secukinumab, with
other biologics and apremilast in patients with Psoriatic arthritis (PsA) from payer …
other biologics and apremilast in patients with Psoriatic arthritis (PsA) from payer …